Windtree Therapeutics to Host Virtual R&D and Investor Day Focusing on the Cardiogenic Shock Market, Istaroxime, Company Strategy and Planned Near-Term Milestones
Virtual event to take place on June 14, 2023 at 1:00 pm ET WARRINGTON, Pa. , June 05, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics , Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today
Article Date
June 5, 2023
This article is featured on another website.
Go to article
April 28, 2026
Clinical Research Consulting vs. FSP in Biotech and Pharma: Knowing When an FSP Is the Right Fit
Clinical Research Consulting vs. FSP: Choosing the Right Model for Biotech and Pharma Companies Biotech…
April 28, 2026
Clinical Research Consulting vs. FSP in Biotech and Pharma: Knowing When an FSP Is the Right Fit
Clinical Research Consulting vs. FSP: Choosing the Right Model for Biotech and Pharma Companies Biotech…